HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Radioimmunoscintigraphy of orbital metastases from ovarian carcinoma.

Abstract
Radioimmunoscintigraphy with I-123 labeled monoclonal antibody HMFG1 has been used for imaging primary and metastatic ovarian neoplasms. Uptake of I-123 labeled HMFG1 is reported in a patient with an orbital metastasis from a primary ovarian adenocarcinoma. Radioimmunoscintigraphy may have a role to play in imaging metastatic orbital neoplasms.
AuthorsJ Bomanji, J Glaholm, J L Hungerford, S J Mather, M Granowska, K E Britton, R Whitelocke
JournalClinical nuclear medicine (Clin Nucl Med) Vol. 15 Issue 11 Pg. 825-7 (Nov 1990) ISSN: 0363-9762 [Print] UNITED STATES
PMID2292158 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • Iodine Radioisotopes
Topics
  • Adenocarcinoma (radionuclide imaging, secondary)
  • Aged
  • Antibodies, Monoclonal
  • Female
  • Humans
  • Iodine Radioisotopes
  • Orbital Neoplasms (radionuclide imaging, secondary)
  • Ovarian Neoplasms (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: